Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on June 12, 2025
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
GlobeNewswire
·
June 12, 2025
Gabrail Cancer …
Centurion Service Group to auction all assets following the closure of Rockledge Hospital in Rockledge, FL
GlobeNewswire
·
June 12, 2025
Franklin Park, Illinois, June 12, 2025 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment life-cycle company, has been selected to auction all medical and non-medical assets of Rockledge Hospital in Rockledge, FL. All …
Private Donors Give $350,000 To Precision Medicine Study for Colorectal Cancer Patients
GlobeNewswire
·
June 12, 2025
Springfield, Mo., June 12, 2025 (GLOBE NEWSWIRE) -- Philanthropic support from private donors is what’s helping fund a new study focused on advancing precision medicine for metastatic colorectal cancer patients. The Ron and Martha Doornink Foundation is …
Catheter Precision, Inc. Comments on Recent Market Activity
GlobeNewswire
·
June 12, 2025
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in …
Global Uterine Fibroids Treatment Devices Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2032 | DelveInsight
GlobeNewswire
·
June 12, 2025
New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Global Uterine Fibroids Treatment Devices Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2032 | DelveInsight The growing prevalence of uterine fibroids, especially among women of …
Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight
GlobeNewswire
·
June 12, 2025
New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Giant-cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved …
First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient
GlobeNewswire
·
June 12, 2025
RIYADH, Saudi Arabia, June 12, 2025 (GLOBE NEWSWIRE) -- In a medical achievement considered the first of its kind in the region, King Faisal Specialist Hospital …
Syndax Announces Publication of Revumenib Data from the BEAT AML Trial in the Journal of Clinical Oncology and Simultaneous Presentation at EHA 2025
GlobeNewswire
·
June 12, 2025
– Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed with 67% (29/43) CR rate, 88% (38/43) ORR, and 100% (37/ …
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
GlobeNewswire
·
June 12, 2025
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
GlobeNewswire
·
June 12, 2025
Addition of TUS to standard of care VEN+AZA creates a well-tolerated and mutation agnostic frontline triple drug therapy for newly diagnosed AML AML patients with diverse mutations, including TP53-mutated/CK and FLT3-wildtype, safely achieved complete …
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial
GlobeNewswire
·
June 12, 2025
Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for Psychedelic Research located at the Sagol Brain Institute (SGI) in Tel-Aviv …
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
GlobeNewswire
·
June 12, 2025
PORTOLA VALLEY, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has given its 2025 Emerging Leader Award (ELA) to Chao Wang, PhD, associate professor in the School of Electrical, …
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029
GlobeNewswire
·
June 12, 2025
Boston, June 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Implantable Remote Patient Monitoring Devices Market” is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound …
Mama Bird Launches in Sprouts Farmers Market Nationwide With Brain-First Supplements for Families
GlobeNewswire
·
June 12, 2025
DENVER, June 12, 2025 (GLOBE NEWSWIRE) -- Mama Bird® is hatching at Sprouts this season! Mama Bird, maker of brain-boosting vitamins for families, is excited to announce that four of its best-selling prenatal and kids’ vitamins are now available at Sprouts …
Spark Biomedical Completes Enrollment in a Neurostimulation Pivotal Trial for Opioid Use Disorder
GlobeNewswire
·
June 12, 2025
Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve treatment retention for adults with opioid use disorder. Funded …
Plant-based Supplements Market to Reach USD 42.27 Billion by 2030, Fuelled by Personalized Wellness Trends and Rising Global Demand
GlobeNewswire
·
June 12, 2025
Delray Beach, FL, June 12, 2025 (GLOBE NEWSWIRE) -- According to a recent research report published by MarketsandMarkets titled "Plant-based Supplements Market by Product Type, Supplement Form, Age Group, End-use, Distribution Channel, and Region – Global …
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
GlobeNewswire
·
June 12, 2025
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical …
Hematologists Set the Stage for Market Disruption as Next-Gen Hemophilia Therapies Gain Traction
GlobeNewswire
·
June 12, 2025
EXTON, PA, June 12, 2025 (GLOBE NEWSWIRE) -- As the hemophilia landscape continues to transform, new research from Spherix Global Insights reveals a market on the cusp of significant evolution driven by innovation, physician receptivity, and an …
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
GlobeNewswire
·
June 12, 2025
1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the …
RadioMedix Debuts Proprietary bench top ²¹²Pb Generator to Support Targeted Alpha Therapy Development
GlobeNewswire
·
June 12, 2025
HOUSTON, June 12, 2025 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and cancer therapy, today announced the launch of RAHA-100, its proprietary, …